Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN
 

Infectious disease

C&EN 中文版

瑞德西韦的初步数据对治疗COVID-19的意义

吉利德科学公司的抗病毒药正处于多个治疗冠状病毒感染的后期试验中。传染病专家表示,不要期望全垒打

by Lisa M. Jarvis
April 6, 2020 | A version of this story appeared in Volume 98, Issue 13

Article:

This article has been sent to the following recipient: